Advertisement

Management of Intoxications in Pediatrics

  • Rupesh RainaEmail author
  • Stephanie Lam
  • Hershita Raheja
  • Michelle Bestic
  • Martha Blackford
Chapter

Abstract

Poisonings in pediatrics remains a consistent cause for presentation to emergency departments. According to the 2016 34th annual report of the American Association of Poison Control Centers’, children <3 years of age accounted for 34.7% of all exposures and children ≤5 years of age accounted for 50% of all exposures. The top three most common poisonings were analgesics, household cleaning substances, and cosmetics/personal care products. Overall, compared to the 2015 data, there was an overall decline in number of reported fatalities in children <20 years old. In children <6 years of age, there were 24 reported deaths. Most common causes were fumes/gases/vapors. Among children between 6 and 12 years old, there were seven reported deaths with the most common cause listed as analgesic exposure. In adolescents aged 13–19 years old, there were 42 reported fatalities with the most common cause listed as analgesics [1] (see Table 21.2).

References

  1. 1.
    Gummin DD, et al. 2016 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th annual report. Clin Toxicol (Phila). 2017;55(10):1072–252.CrossRefGoogle Scholar
  2. 2.
    Rademacher S, Oppert M, Jorres A. Artificial extracorporeal liver support therapy in patients with severe liver failure. Expert Rev Gastroenterol Hepatol. 2011;5(5):591–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Askenazi DJ, Goldstein SL, Chang IF, Elenberg E, Feig DI. Management of a Severe Carbamazepine Overdose Using Albumin-Enhanced Continuous Venovenous Hemodialysis. Pediatrics. 2004;133(2):406–9.CrossRefGoogle Scholar
  4. 4.
    Churchwell MD, Pasko DA, Smoyer WE, Mueller BA. Enhanced clearance of highly protein bound drugs by albumin supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant. 2009;24:231–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Collins KL, Roberts EA, Adeli K, Bohn D, Harvey EA. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol. 2008;23:1013–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Mitzner SR, Stange J. Albumin dialysis with molecular adsorbent recirculating system in the treatment of liver failure. In: Critical care nephrology. Philadelphia: Saunders; 2008. p. 1539–43.Google Scholar
  7. 7.
    Harbord N, Feinfeld DA, Winchester JF. Hemodialysis, hemofiltration, and hemoperfusion in acute intoxication and poisoning. In: Critical care nephrology. Philadelphia: Saunders; 2008. p. 919–25.Google Scholar
  8. 8.
    Kumar PP, et al. Charcoal hemoperfusion for phenytoin intoxication. Indian Pediatr. 2012;49(2):152–3.PubMedGoogle Scholar
  9. 9.
    Shalkham AS, et al. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis. 2006;48(2):239–41.PubMedCrossRefGoogle Scholar
  10. 10.
    Nemoto T, et al. Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failure. Pediatr Hematol Oncol. 2009;26(7):520–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Borkan SC. Extracorporeal therapies for acute intoxications. Crit Care Clin. 2002;18:393–420.PubMedCrossRefGoogle Scholar
  12. 12.
    Misanovic V, et al. Plasmapheresis in pediatric intensive care unit. Med Arch. 2016;70(5):332–5.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Nenov VD, Marinov P, Sabeva J, Nenov DS. Current applications of plasmapheresis in clinical toxicology. Nephrol Dial Transplant. 2003;18(Suppl 5):v56–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Cox RD, Phillips WJ. Ethylene glycol toxicity. Mil Med. 2004;169(8):660–3.PubMedCrossRefGoogle Scholar
  15. 15.
    Kuang D, Ronco C, NA H. Poisoning: kinetics to therapeutics. In: Critical care nephrology. Philadelphia: Saunders; 2008. p. 931–54.Google Scholar
  16. 16.
    Wiley JF. Novel therapies for ethylene glycol intoxication. Curr Opin Pediatr. 1999;11(3):269–73.PubMedCrossRefGoogle Scholar
  17. 17.
    Jacobsen D, Hovda KE. Methanol, ethylene glycol, and other toxic alcohols. In: Haddad and Winchester’s clinical management of poisoning and drug overdose. Philadelphia: Saunders; 2007. p. 605–21.Google Scholar
  18. 18.
    Goldfrank LR, et al. Goldfrank’s toxicologic emergencies. 8th ed. New York: McGraw Hill; 2006.Google Scholar
  19. 19.
    Tadokoro M, et al. A case of acute renal failure due to ethylene glycol intoxication. Nihon Jinzo Gakkai Shi. 1995;37(6):353–6.PubMedGoogle Scholar
  20. 20.
    Schwerk N, et al. Successful therapy of paediatric ethylene glycol poisoning: a case report and annual survey by a regional poison centre. Acta Paediatr. 2007;96(3):461–3.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Litovitz T. The alcohols: ethanol, methanol, isopropanol, ethylene glycol. Pediatr Clin N Am. 1986;33(2):311–23.CrossRefGoogle Scholar
  22. 22.
    Stapenhorst L, Hesse A, Hoppe B. Hyperoxaluria after ethylene glycol poisoning. Pediatr Nephrol. 2008;23(12):2277–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Brent J. Current management of ethylene glycol poisoning. Drugs. 2001;61(7):979–88.PubMedCrossRefGoogle Scholar
  24. 24.
    Hirsch DJ, et al. A simple method to estimate the required dialysis time for cases of alcohol poisoning. Kidney Int. 2001;60(5):2021–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Brent J. Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings. Clin Toxicol (Phila). 2010;48(5):401–6.CrossRefGoogle Scholar
  26. 26.
    Loza R, Rodriguez D. A case of methanol poisoning in a child. Case Rep Nephrol. 2014;2014:652129.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Barceloux DG, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40(4):415–46.PubMedCrossRefGoogle Scholar
  28. 28.
    Sutton TL, Foster RL, Liner SR. Acute methanol ingestion. Pediatr Emerg Care. 2002;18(5):360–3.PubMedCrossRefGoogle Scholar
  29. 29.
    Roberts DM, et al. Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Crit Care Med. 2015;43(2):461–72.PubMedCrossRefGoogle Scholar
  30. 30.
    Brown MJ, et al. Childhood methanol ingestion treated with fomepizole and hemodialysis. Pediatrics. 2001;108(4):E77.PubMedCrossRefGoogle Scholar
  31. 31.
    Gibson PJ, Cant AJ, Mant TG. Ethanol poisoning. Acta Paediatr Scand. 1985;74(6):977–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Gormley NJ, et al. The rising incidence of intentional ingestion of ethanol-containing hand sanitizers. Crit Care Med. 2012;40(1):290–4.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Slaughter RJ, et al. Isopropanol poisoning. Clin Toxicol (Phila). 2014;52(5):470–8.CrossRefGoogle Scholar
  34. 34.
    Church AS, Witting MD. Laboratory testing in ethanol, methanol, ethylene glycol, and isopropanol toxicities. J Emerg Med. 1997;15(5):687–92.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Wiener SW. Toxic alcohol. In: Goldfrank’s Toxicologic emergencies. New York: McGraw-Hill; 2014. p. 1346–53.Google Scholar
  36. 36.
    Stremski E, Hennes H. Accidental isopropanol ingestion in children. Pediatr Emerg Care. 2000;16(4):238–40.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Baird-Gunning J, et al. Lithium poisoning. J Intensive Care Med. 2017;32(4):249–63.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Decker BS, et al. Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Nephrol. 2015;10(5):875–87.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Bruns AS, Sebestyen J. Twelve-year-old female with nausea, vomiting, edema, tremor, and slurred speech. Clin Pediatr (Phila). 2015;54(2):194–6.CrossRefGoogle Scholar
  40. 40.
    McLean MM, et al. A 17-year-old female patient with a Lithium overdose. Air Med J. 2015;34(4):162–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Meyer RJ, et al. Hemodialysis followed by continuous hemofiltration for treatment of lithium intoxication in children. Am J Kidney Dis. 2001;37(5):1044–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Groleau G. Lithium toxicity. Emerg Med Clin North Am. 1994;12(2):511–31.PubMedGoogle Scholar
  43. 43.
    Fischbach M, et al. Hemodialysis in children: general practical guidelines. Pediatr Nephrol. 2005;20(8):1054–66.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med. 2012;367(26):2505–14.PubMedCrossRefGoogle Scholar
  45. 45.
    Ogilvie JD, Rieder MJ, Lim R. Acetaminophen overdose in children. CMAJ. 2012;184(13):1492–6.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Marzullo L. An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr Opin Pediatr. 2005;17(2):239–45.PubMedCrossRefGoogle Scholar
  47. 47.
    Shannon M, Borron S, Burns M. Haddad and Winchester’s clinical management of poisoning and drug overdose. Philadelphia: Saunders; 2007. p. 825–31.CrossRefGoogle Scholar
  48. 48.
    Keays R, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809):1026–9.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Squires RH, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652–8.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Ghannoum M, et al. Massive acetaminophen overdose: effect of hemodialysis on acetaminophen and acetylcysteine kinetics. Clin Toxicol (Phila). 2016;54(6):519–22.CrossRefGoogle Scholar
  51. 51.
    Mirrakhimov AE, et al. The role of renal replacement therapy in the management of pharmacologic poisonings. Int J Nephrol. 2016;2016:3047329.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J. 2002;19(3):206–9.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Rivera W, et al. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion. Ann Pharmacother. 2004;38(7–8):1186–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Lugassy D. Salicylates. In: Hoffman R, Howland M, Lewin N, Nelson L, Goldfrank L, editors. Goldfrank’s toxicologic emergencies. New York: McGraw-Hill; 2015.Google Scholar
  55. 55.
    Juurlink DN, et al. Extracorporeal treatment for salicylate poisoning: systematic review and recommendations from the EXTRIP workgroup. Ann Emerg Med. 2015;66(2):165–81.PubMedCrossRefGoogle Scholar
  56. 56.
    Muniandy RK, Sinnathamby V. Salicylate toxicity from ingestion of traditional massage oil. BMJ Case Rep. 2012;2012.  https://doi.org/10.1136/bcr-2012-006562.Google Scholar
  57. 57.
    Papacostas MF, et al. Use of continuous renal replacement therapy in salicylate toxicity: a case report and review of the literature. Heart Lung. 2016;45(5):460–3.PubMedCrossRefGoogle Scholar
  58. 58.
    Fisher J, Graudins A. Intermittent haemodialysis and sustained low-efficiency dialysis (SLED) for acute theophylline toxicity. J Med Toxicol. 2015;11(3):359–63.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Ghannoum M, et al. Extracorporeal treatment for theophylline poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2015;53(4):215–29.CrossRefGoogle Scholar
  60. 60.
    Ma YJ, et al. Theophylline: a review of population pharmacokinetic analyses. J Clin Pharm Ther. 2016;41(6):594–601.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Yaman A, et al. Severe theophylline poisoning treated with continuous venovenous hemodialysis in a child. Turk J Pediatr. 2016;58(3):297–300.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Mactier R, et al. Extracorporeal treatment for barbiturate poisoning: recommendations from the EXTRIP workgroup. Am J Kidney Dis. 2014;64(3):347–58.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Söylemezoğlu O, et al. Haemodialysis treatment in phenobarbital intoxication in infancy. Int Urol Nephrol. 1993;25(1):111–3.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Kihtir HS, et al. Single-pass albumin dialysis in a child aged six months with phenobarbital poisoning. Turk Pediatri Ars. 2016;51(4):228–30.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Goktas U, Kati I, Yuce HH. Management of a severe carbamazepine overdose with continuous venovenous hemodiafiltration. Am J Emerg Med. 2010;28(2):260.e1–2.CrossRefGoogle Scholar
  66. 66.
    Ghannoum M, et al. Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2014;52(10):993–1004.CrossRefGoogle Scholar
  67. 67.
    Yildiz TS, et al. Continuous venovenous hemodiafiltration to treat controlled-release carbamazepine overdose in a pediatric patient. Paediatr Anaesth. 2006;16(11):1176–8.PubMedGoogle Scholar
  68. 68.
    Anseeuw K, et al. Extracorporeal treatment in phenytoin poisoning: systematic review and recommendations from the EXTRIP (extracorporeal treatments in poisoning) workgroup. Am J Kidney Dis. 2016;67(2):187–97.PubMedCrossRefGoogle Scholar
  69. 69.
    Fischer JH, Patel TV, Fischer PA. Fosphenytoin clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Clin Pharmacokinet. 2003;42:33–58.PubMedCrossRefGoogle Scholar
  70. 70.
    Singh S, Rathore S, Verma DK, Kumar P, Bhatia BD. Tandem plasmapheresis with hemodialysis in phenytoin intoxication: a case report. Int J Adv Med. 2015;2(3):269–71.CrossRefGoogle Scholar
  71. 71.
    Dönmez O, Cetinkaya M, Canbek R. Hemoperfusion in a child with amitriptyline intoxication. Pediatr Nephrol. 2005;20(1):105–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Presley JD, Chyka PA. Intravenous lipid emulsion to reverse acute drug toxicity in pediatric patients. Ann Pharmacother. 2013;47(5):735–43.PubMedCrossRefGoogle Scholar
  73. 73.
    Mutlu M, et al. Charcoal hemoperfusion in an infant with supraventricular tachycardia and seizures secondary to amitriptyline intoxication. Hum Exp Toxicol. 2011;30(3):254–6.PubMedCrossRefGoogle Scholar
  74. 74.
    Bek K, et al. Charcoal haemoperfusion in amitriptyline poisoning: experience in 20 children. Nephrology (Carlton). 2008;13(3):193–7.CrossRefGoogle Scholar
  75. 75.
    Karaci M, et al. Severe childhood amitriptyline intoxication and plasmapheresis: a case report. Turk J Pediatr. 2013;55(6):645–7.PubMedGoogle Scholar
  76. 76.
    Kolsal E, Tekin I, Cumhur A, Akyuz M, Cabuk H, Eldes N, Numanoglu V. Treatment of severe amitriptyline intoxication with plasmapheresis. J Clin Apher. 2009;24:21–4.PubMedCrossRefGoogle Scholar
  77. 77.
    Ghannoum M, et al. Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2015;53(5):454–65.CrossRefGoogle Scholar
  78. 78.
    Thanacoody RH. Extracorporeal elimination in acute valproic acid poisoning. Clin Toxicol (Phila). 2009;47(7):609–16.CrossRefGoogle Scholar
  79. 79.
    Mock CM, Schwetschenau KH. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm. 2012;69(1):35–9.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Tsai MF, Chen CY. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis. Ren Fail. 2008;30(8):822–4.PubMedCrossRefGoogle Scholar
  81. 81.
    Dharnidharka VR, Fennell RS, Richard GA. Extracorporeal removal of toxic valproic acid levels in children. Pediatr Nephrol. 2002;17(5):312–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Rupesh Raina
    • 1
    • 2
    Email author
  • Stephanie Lam
    • 3
  • Hershita Raheja
    • 2
  • Michelle Bestic
    • 3
  • Martha Blackford
    • 3
  1. 1.Department of NephrologyCleveland Clinic Akron General and Akron Children’s HospitalAkronUSA
  2. 2.Akron Nephrology Associates/Cleveland Clinic Akron GeneralAkronUSA
  3. 3.Department of PediatricsAkron Children’s HospitalAkronUSA

Personalised recommendations